https://www.selleckchem.com/pr....oducts/ag-221-enasid
Previous publications have indicated that the purinergic signaling activity in insulin resistance and glucose transporters modulates relevant actions on the deregulations that can affect glycemic homeostasis. Thus, this review focuses on the pharmacological influence of purinergic signaling on the modulation of glucose transporters, aiming for a new way to combat insulin resistance and other metabolic disorders.Over the past decade, dexmedetomidine (DEX) has been found to possess an anti-inflammatory effect. However, the local
Like
Comment
Share
